The effect of ORS-bicarbonate and ORS-citrate, the two established oral rehydration therapies of World Health Organization, on pH and bicarbonate levels of blood was studied in ninety-six human subjects (diarrhoeal and normal); of which fifty percent were children under the age of ten years and remaining fifty percent adults were of the age over fifteen years. These two parameters were observed immediately before and one hour after the administration of either of the recipes to mild and moderately dehydrated and control subject. These findings revealed that ORS-bicarbonate caused a significant (P) rise in blood pH of normal children and adults, while diarrhoeal individuals (children and adults) did not show this change in the pH of blood. However, ORS-bicarbonate therapy induced a significant (P) rise in blood bicarbonate concentration of children and adults in normal and diarrhoeal conditions associated with dehydration and acidosis. Conversely, the ORS-citrate therapy did manage to alter the pH and bicarbonate levels to a little extent but not a significant level (P0.05). Based on the previous facts both the formulations have got similar efficacy in diarrhoeal subjects. Our data suggest that ORS-bicarbonate, having shorter shelf-life, could be replaced by ORS- citrate; a more stable formulation without losing clinical efficacy.